In a cohort study with long COVID-19 and non-long COVID-19 patients, Phetsouphanh and colleagues (2022) identified higher IFN type I (IFN-α and IFN-β) 8 months after SARS-CoV-2 infection (38). This evidence concerns the gene IFNA17 and COVID-19.